Home
Query results
Results for
PDE4DIP
Expand for information on PDE4DIP
PDE4DIP
Description
phosphodiesterase 4D interacting protein
Aliases
CMYA2, MMGL
Gene Identifiers
mRNA Identifiers
RefSeq (mRNA)
NM_001002810.4; NM_001002811.2; NM_001002812.3; NM_001195260.1; NM_001195261.1; NM_001198832.3; NM_001198834.4; NM_001350520.1; NM_001350521.3; NM_001350522.2; NM_001350523.2; NM_001377392.1; NM_001377393.1; NM_014644.6; NM_022359.7; XM_005272981.4; XM_005277442.5; XM_006711642.3; XM_006711643.3; XM_006711646.2; XM_006711648.3; XM_006711650.4; XM_006711651.1; XM_006711652.1; XM_011510172.2; XM_011510173.2; XM_011510174.2; XM_011510175.2; XM_011510176.2; XM_011510179.1; XM_017002875.2; XM_017002876.2; XM_017002879.2; XM_017002881.2; XM_017002882.2; XM_017002883.2; XM_017002884.2; XM_017002885.2; XM_017002886.2; XM_017002887.1; XM_017002888.1; XM_017002889.2; XM_017002890.2; XM_017002891.2; XM_017002892.2; XM_017002893.1; XM_017002894.2; XM_017002895.2; XM_017002896.2; XM_017002897.2; XM_017002900.2; XM_017002901.2; XM_017002903.2; XM_024451067.1; XM_024451068.1
Protein Identifiers
RefSeq (protein)
NP_001002810.1; NP_001002811.2; NP_001002812.2; NP_001182189.1; NP_001182190.1; NP_001185761.2; NP_001185763.3; NP_001337449.1; NP_001337450.1; NP_001337451.1; NP_001337452.1; NP_001364321.1; NP_001364322.1; NP_055459.5; NP_071754.3; XP_005273038.2; XP_005277499.2; XP_006711705.1; XP_006711706.1; XP_006711709.1; XP_006711711.1; XP_006711713.1; XP_006711714.1; XP_006711715.1; XP_011508474.1; XP_011508475.1; XP_011508476.1; XP_011508477.1; XP_011508478.1; XP_011508481.1; XP_016858364.1; XP_016858365.1; XP_016858368.1; XP_016858370.1; XP_016858371.1; XP_016858372.1; XP_016858373.1; XP_016858374.1; XP_016858375.1; XP_016858376.1; XP_016858377.1; XP_016858378.1; XP_016858379.1; XP_016858380.1; XP_016858381.1; XP_016858382.1; XP_016858383.1; XP_016858384.1; XP_016858385.1; XP_016858386.1; XP_016858389.1; XP_016858390.1; XP_016858392.1; XP_024306835.1; XP_024306836.1
Uniprot ID
Ensembl protein ID
Protein Architecture
SMART
Disease Mapping
Druggability
- Candidate cancer driver
- Damaged in 345/7921 TCGA samples
- Damaged in 43/1291 cell lines
- Fewer loss of function mutations
- Equal damaging SNVs/indels
- Fewer structural variants